Erik Hahn, MS (he/him/his)

Associate Director Clinical Pharmacology - Oncology
Pfizer, Inc.

Poster(s):

• (S-105) POPULATION PHARMACOKINETIC (POPPK) MODELING OF IRINOTECAN AND SN38 IN PARTICIPANTS WITH METASTATIC COLORECTAL CANCER (MCRC) IN PHASE 2 AND 3 STUDIES: A SEQUENTIAL PARENT-METABOLITE MODEL
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT